[Disclosure] Alteogen(196170) Designated as ‘Investment Warning Stock’; Takes Effect from February 28

Source Fact: Financial Supervisory Service DART / 2024-02-27

Disclosure Type: Designation of Investment Warning Stock

💡 3-Second Summary

Following a dramatic short-term and mid-term rally where its stock price surged over 60% in 5 days and 100% in 15 days, Alteogen has been formally designated as an ‘Investment Warning Stock’ effective February 28, suspending margin trading and exposing the stock to potential trading halts upon further sharp increases.

📊 1. [Summary of Core Disclosure Content and Major Figures]

• Target Stock: Alteogen Co., Ltd. Common Stock (Ticker: 196170)
• Effective Date of Designation: February 28, 2024
• Reason for Designation: All Short-term and Mid-term regulatory conditions were fulfilled following a prior warning notice:
  • Short-term Parameters: The closing price on February 27, 2024, surged by 60% or more compared to the closing price 5 trading days prior, marked the highest closing price within the past 15 consecutive trading days, and its 5-day rate of appreciation was at least 5 times that of the composite stock price index over the same period.
  • Mid-term Parameters: The closing price on February 27, 2024, surged by 100% or more compared to the closing price 15 trading days prior, marked the highest closing price within the past 15 consecutive trading days, and its 15-day rate of appreciation was at least 3 times that of the composite stock price index over the same period.
• Trading Suspension Condition: If the stock price advances by 40% or more within 2 trading days post-designation and stays higher than the closing price of the day prior to designation, trading may be temporarily suspended for a single instance.
• Criteria for Potential De-designation: Starting 10 trading days after designation, with March 13, 2024, set as the initial tentative judgment date (T), the status will be lifted on the following day if the stock does not meet any of the following parameters (otherwise delayed daily):
  1. The closing price on day T is 60% or higher than the closing price 5 trading days prior (T-5, tentatively March 06).
  2. The closing price on day T is 100% or higher than the closing price 15 trading days prior (T-15, tentatively February 20).
  3. The closing price on day T is the highest closing price within the past 15 consecutive trading days.
• Key Transaction Restrictions:
  • Entails a 100% upfront cash deposit requirement for new purchases.
  • Ban on margin trading (credit loans).
  • Excluded from substitute securities allocation.
  • Subject to potential ‘Investment Risk Stock’ upgrade upon sustained surges.
  • Upon de-designation, the stock will concurrently be designated as an ‘Investment Caution Stock’.

📈 2. [Expert View: What This Disclosure Means for Investors]

This filing indicates a regulatory market intervention enforced by the Korea Exchange (KRX) to manage heightened volatility stemming from rapid upward price vectors. It functions strictly as a structural trading restriction governed by quantitative price thresholds rather than an announcement identifying alterations in Alteogen’s pipeline milestones, biological research developments, or financial fundamental.

From a market mechanics perspective, this regulatory classification may introduce a near-term liquidity cooling effect. Beginning February 28, the total restriction on utilizing credit leverage and the mandatory 100% cash requirement effectively restrict speculative capital inflows. Furthermore, market participants should factor in the operational risk of a temporary trading halt if a 40% gain occurs within the immediate two-day post-designation window. A balanced strategy requires monitoring price distributions relative to the upcoming de-designation evaluation on March 13, as compressed short-term liquidity typically alters intraday volatility parameters.

📝 Editor’s Comment (by K-STOCK Editor)

Alteogen’s relentless market rally has officially crossed the regulatory threshold, landing it firmly into the ‘Investment Warning Stock’ tier. A vertical expansion over the past few weeks has prompted the KRX to apply the brakes after the stock heavily outpaced the benchmark index. Starting February 28, investors lose the ability to deploy margin debt, and the 100% upfront cash requirement will inevitably choke off leveraged buying volumes. With the threat of a trading suspension looming if the stock climbs another 40% over the next two sessions, investors should prioritize risk mitigation over aggressive momentum trading until this regulatory phase cools down around the evaluation window in mid-March.

📢 Disclaimer and Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.